Rice and the United States Army Engineer Research and Development Center (ERDC) have signed an Education Partnership Agreement in formal recognition of their collaboration as part of Improving Access to Career and Educational Development (I-ACED).
A team of Rice researchers mapped out how flecks of 2D materials move in liquid ⎯ knowledge that could help scientists assemble macroscopic-scale materials with the same useful properties as their 2D counterparts.
Rice University today announced that Motif Neurotech, a neurotechnology developing minimally invasive bioelectronics for mental health formed through the Rice Biotech Launch Pad, closed an oversubscribed Series A financing round of $18.75 million.
Rice scientists in the lab of Angel Martí have uncovered a new way to make high-purity boron nitride nanotubes, hollow cylindrical structures that can withstand temperatures of up to 900 degrees Celsius while also being stronger than steel by weight.
The Rice Synthetic Biology Institute aims to catalyze collaborative research in synthetic biology and its translation into technologies that benefit society.
Rice-engineered synthetic serum marker can track gene expression in the brain noninvasively, using blood tests.
Rice University today announced the addition of Robert Ruffolo Jr. to its external advisory board for the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
A five-year grant from the National Institutes of Health (NIH) will support the development of an innovative undergraduate bioengineering curriculum component intended to cultivate inclusive design principles for Rice students contemplating a career as medical practitioners or medical technology innovators.
Rice University swimmer and recent graduate Ahalya Lettenberger is one of 51 students nationwide selected for a 2024 Marshall Scholarship, it was announced Dec. 11.
Rice University and its Biotech Launch Pad today announced a peer-reviewed publication in Nature Communications detailing the development of a novel and rechargeable device — an electrocatalytic on-site oxygenator (ecO2) that produces oxygen to keep cells alive inside an implantable “living pharmacy,” potentially improving the outcomes of cell-based therapies.
Rice University’s Gang Bao is available to comment on today’s decision by the FDA on whether or not to approve a CRISPR-based therapy for sickle cell disease.
A Rice-led collaboration of engineers, oncologists and global health partners from three continents is establishing a research center in the Texas Medical Center to develop affordable, effective point-of-care (POC) technologies to improve early cancer detection in low-resource settings in the United States and other countries.
Rice University today announced the addition of Kevin Sheridan to its external advisory board for the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
Rice neuroengineers designed the first self-rectifying magnetoelectric material and showed it can not only precisely stimulate neurons remotely but also reconnect a broken sciatic nerve in a rat model.
Rice bioengineers developed a tool that activates silent or insufficiently expressed genes using human-derived building blocks and a CRISPR-based genome-targeting platform.